Please use this identifier to cite or link to this item:
|Title:||Alkaloid extracts from Bitter leaf (Vernonia amygdalina) and Black nightshade (Solanum nigrum) inhibit phosphodiesterase‐5, arginase activities and oxidative stress in rats penile tissue|
|Authors:||Omojokun, Olasunkanmi S.|
Famurewa, Akindele J.
Jaiyeoba, Oluwademilade A.
Agbebi, Oluwaseun J.
|Citation:||Omojokun, O. S., Famurewa, A. J., Jaiyeoba, O. A., Oboh, G., & Agbebi, O. J. (2019). Alkaloid extracts from Bitter leaf ( Vernonia amygdalina ) and Black nightshade ( Solanum nigrum ) inhibit phosphodiesterase‐5, arginase activities and oxidative stress in rats penile tissue. Journal of Food Biochemistry, e12889. doi:10.1111/jfbc.12889|
|Abstract:||The erectogenic potential of alkaloids extracted from Bitter leaf (Vernonia amygdalina) and Black nightshade (Solanum nigrum) was investigated in this study. Fresh leaves obtained from Bitter leaf and Black night shade were air‐dried, pulverized, and extracted for alkaloids. The inhibitory potential of the alkaloid extracts on arginase and phosphodiesterase‐5 (PDE‐5) activities in rats penile tissue was determined in vitro. The antioxidant properties were also evaluated and the constituent alkaloids quantified using GC‐MS. The alkaloid extracts inhibited arginase (0–30.51 μg/ml) and PDE‐5 (0–133.69 μg/ml) activities in a concentration‐dependent pattern. Similarly, the alkaloid extracts inhibited Fe2+‐induced lipid peroxidation in rats penile tissues, scavenged DPPH, OH, and NO radicals as a function of concentration. GC‐MS characterization revealed over 20 alkaloid compounds. The inhibition of PDE‐5‐, arginase‐, pro‐oxidant‐induced lipid peroxidative‐, and free radicals‐scavenging activities by the alkaloids is suggestive of putative mechanisms underlying their therapeutic use for managing erectile dysfunction in folklore medicine. Practical applications Alkaloids extracted from Black nightshade (Solanum nigrum) and Bitter leaf (Vernonia amygdalina) were characterized and investigated by standard procedures for inhibitory action against key erectile dysfunction‐linked enzymes and antioxidant activity. The alkaloids inhibited erectile dysfunction‐linked enzymes (arginase and PDE‐5) and showed considerable antioxidant activity in a concentration‐dependent manner. In view of this, we suggest the application of these results in the development of erectile dysfunction drugs in the pharmaceutical industry, with probable minimal or no adverse effect.|
|Appears in Collections:||Research Articles|
Files in This Item:
|email@example.com||819.81 kB||Adobe PDF|
Items in EUSpace are protected by copyright, with all rights reserved, unless otherwise indicated.